TY - JOUR
T1 - Identifying Factors Associated with Disparities in Accessing an Integrative Oncology Program
AU - Samuels, Noah
AU - Gressel-Raz, Orit
AU - Peled, Nir
AU - Stein, Nili
AU - Granot, Inbal
AU - Ben-Arye, Eran
N1 - Publisher Copyright:
© 2024 American Academy of Hospice and Palliative Medicine
PY - 2025/3
Y1 - 2025/3
N2 - Introduction: Integrative oncology (IO) programs provide patients with evidence-based complementary medicine therapies within a supportive and palliative cancer care setting. This study retrospectively examined characteristics of patients with lung cancer predicting utilization of a freely-provided IO consultation at two medical centers in Israel. Methods: Electronic medical files of 832 patients with lung cancer attending/not attending the IO consultation were searched for socio-demographic (age, gender, country of birth, place of residence, primary language spoken) and personal health (Body Mass Index; smoking; disability) characteristics; cancer-related parameters (primary tumor site, localized vs. metastatic); and reported pain- and emotional-related concerns. Results: Only 120 (14.4%) of eligible patients attended the IO consultation, with multivariate analysis finding a significantly lower likelihood of attendance among patients who were older (OR: 0.98, 95% CI = 0.96-0.99; P = 0.02); male (OR: 0.53, 95% CI = 0.34-0.83; P = 0.005); primarily non Hebrew-speaking (i.e., primarily Arabic or Russian speakers; OR: 0.34, 95% CI = 0.14-0.82; P = 0.016); without disability (OR: 0.52, 95% CI = 0.33-0.92; P = 0.025); and not reporting pain (OR = 0.40,95% CI = 0.17-0.98-; P = 0.046). Conclusions: The present study suggests that age, gender and culture-related factors (reflected by the patient's primary language) may contribute to disparities in accessing a freely-provided IO consultation, as shown in a diverse population of patients with lung cancer from two medical centers in Israel. Further research is needed to better understand the role of these programs within a diverse, equitable and inclusive setting of effective and safe integrative care of oncology patients.
AB - Introduction: Integrative oncology (IO) programs provide patients with evidence-based complementary medicine therapies within a supportive and palliative cancer care setting. This study retrospectively examined characteristics of patients with lung cancer predicting utilization of a freely-provided IO consultation at two medical centers in Israel. Methods: Electronic medical files of 832 patients with lung cancer attending/not attending the IO consultation were searched for socio-demographic (age, gender, country of birth, place of residence, primary language spoken) and personal health (Body Mass Index; smoking; disability) characteristics; cancer-related parameters (primary tumor site, localized vs. metastatic); and reported pain- and emotional-related concerns. Results: Only 120 (14.4%) of eligible patients attended the IO consultation, with multivariate analysis finding a significantly lower likelihood of attendance among patients who were older (OR: 0.98, 95% CI = 0.96-0.99; P = 0.02); male (OR: 0.53, 95% CI = 0.34-0.83; P = 0.005); primarily non Hebrew-speaking (i.e., primarily Arabic or Russian speakers; OR: 0.34, 95% CI = 0.14-0.82; P = 0.016); without disability (OR: 0.52, 95% CI = 0.33-0.92; P = 0.025); and not reporting pain (OR = 0.40,95% CI = 0.17-0.98-; P = 0.046). Conclusions: The present study suggests that age, gender and culture-related factors (reflected by the patient's primary language) may contribute to disparities in accessing a freely-provided IO consultation, as shown in a diverse population of patients with lung cancer from two medical centers in Israel. Further research is needed to better understand the role of these programs within a diverse, equitable and inclusive setting of effective and safe integrative care of oncology patients.
KW - Chemotherapy
KW - Cross-cultural
KW - Disparities
KW - Diversity, Equity and inclusion
KW - Integrative oncology
KW - Lung cancer
UR - http://www.scopus.com/inward/record.url?scp=85212874171&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2024.11.022
DO - 10.1016/j.jpainsymman.2024.11.022
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39645057
AN - SCOPUS:85212874171
SN - 0885-3924
VL - 69
SP - e205-e210
JO - Journal of Pain and Symptom Management
JF - Journal of Pain and Symptom Management
IS - 3
ER -